Circulating LTD4 in patients with hepatocellular carcinoma

@article{Zhou2010CirculatingLI,
  title={Circulating LTD4 in patients with hepatocellular carcinoma},
  author={Yan Zhou and Dongmei Guo and Huiyu Li and Sheng-hua Jie},
  journal={Tumor Biology},
  year={2010},
  volume={32},
  pages={139-144}
}
Hepatocellular carcinoma (HCC) is a type of inflammation-related cancer that usually follows chronic inflammations. Leukotriene D4 (LTD4) is a potent biologically active arachidonic acid-derived lipid mediator that is intimately involved in inflammations and cancers. Although previous researches found overexpression of LTD4 in several other cancers, the circulating LTD4 level in HCC remains unknown. The aim of this study was to examine concentrations of LTD4 and analyze its roles in HCC. The… 
Targeting the eicosanoid pathway in hepatocellular carcinoma.
TLDR
The link between the eicosanoid pathway, inflammation and these liver diseases, and components of the eICosanoids pathway that may be used as potential therapeutic targets in HCC are described and identified.
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding
TLDR
This study demonstrates that leukotriene receptor antagonists could be developed as novel drugs for immunological control and suppression of ADAM9 in HCC, and should be explored as combination therapy partners with conventional multi-kinase inhibitors for developing therapeutic strategies with enhanced efficacies for HCC management and treatment.
Cysteinyl Leukotriene Pathway and Cancer
TLDR
The roles of the CysLT pathway in cancer have been delineated and the chemo-preventive effects of Cys LT1R antagonists were demonstrated in two large retrospective cohort studies.
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
TLDR
It was revealed that the LTRA use decreased cancer risk in a dose-dependent manner in asthma patients, and cancer risk decreased progressively with higher cumulative dose of LTRAs.
Crosstalk between colorectal cancer cells and tumour-associated macrophages
TLDR
Findings provide more evidence that TAMs play an important role in CRC progression and CD47, as a key regulator of crosstalk between colon cancer cells and TAMs, could thus be a therapeutic target for CRC.
Montelukast Induces Apoptosis-Inducing Factor-Mediated Cell Death of Lung Cancer Cells
TLDR
It is shown that feeding montelukast significantly delayed the tumor growth in mice and induced lung cancer cell death via the nuclear translocation of AIF, which confirmed the chemo-preventive effect of montelUKast shown in the previous cohort study.
Menstrual pain and epithelial ovarian cancer risk
TLDR
The data suggest that moderate and severe pain during menstrual period are associated with increased risk of epithelial ovarian cancer, and this observation warrants further studies.
...
...

References

SHOWING 1-10 OF 23 REFERENCES
Inflammation and Liver Cancer
TLDR
The most compelling evidences on the role of transcription factors such as NF‐κB and STAT3, cytokines like IL‐6 and IL‐1α, ligands of the EGF receptor and other inflammatory mediators in cancer development are reviewed, with special emphasis in HCC.
New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system
TLDR
The evidences that support the involvement of the ErbB1 in HCC development and that provide a rationale for Erb B1 targeting in H CC prevention and treatment are reviewed.
Prognostic value of eicosanoid pathways in extrahepatic cholangiocarcinoma.
TLDR
It is demonstrated that 5-LOX and COX-2 protein expression was increased in cholangiocarcinoma suggesting that these two enzymes might be of prognostic value and offer a potential additional adjuvant therapeutic approach to this disease.
Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections.
Leukotrienes induce cell-survival signaling in intestinal epithelial cells.
TLDR
The results suggest that inflammatory conditions are associated with the expression and distribution of proteins that are characteristic of transformed cells; such conditions may involve a signaling mechanism comprising an altered rate of apoptosis.
Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.
TLDR
It is proposed that LT/CysLT(1)R signaling facilitates survival of colon cancer cells, which may affect disease outcome, and like COX-2, LTs are accessible targets for pharmacologic treatment.
Determination of levels of leucotrienes in patients with hepatitis B
TLDR
The level of serum LTD4 reflects the liver damage in the patients with acute or chronic hepatitis B and indicated that LTD4 might play some role in the pathogenesis of hepatitis B.
Effect of leukotrienes on proliferation of human esophageal carcinoma cell line
TLDR
It is indicated that the leukotrienes play an important role in the development of human esophageal carcinoma by non - COX pathway.
Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer.
TLDR
Results indicate that the blockade of the LTB(4)-signaling pathway induces apoptosis via the inhibition of ERK activation in colon cancer cells, which might be a new therapeutic target for colon cancer.
[The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine].
TLDR
It is described how signalling cascades initiated by cysteinyl leukotrienes represent alternative ways in which IBD might progress and lead to the development and propagation of CRC, and as such represent potential targets for future therapeutic regimens to manage chronic inflammatory disorders and cancer.
...
...